Nabriva Therapeutics plc - FORM 10-K - EX-21.1 - March 16, 2018

Attached files

file filename
EX-32.2 - EX-32.2 - Nabriva Therapeutics plca2234062zex-32_2.htm
EX-32.1 - EX-32.1 - Nabriva Therapeutics plca2234062zex-32_1.htm
EX-31.2 - EX-31.2 - Nabriva Therapeutics plca2234062zex-31_2.htm
EX-31.1 - EX-31.1 - Nabriva Therapeutics plca2234062zex-31_1.htm
EX-23.2 - EX-23.2 - Nabriva Therapeutics plca2234062zex-23_2.htm
EX-23.1 - EX-23.1 - Nabriva Therapeutics plca2234062zex-23_1.htm
EX-10.18 - EX-10.18 - Nabriva Therapeutics plca2234062zex-10_18.htm
EX-10.17 - EX-10.17 - Nabriva Therapeutics plca2234062zex-10_17.htm
EX-10.16 - EX-10.16 - Nabriva Therapeutics plca2234062zex-10_16.htm
10-K - 10-K - Nabriva Therapeutics plca2234062z10-k.htm

Exhibit 21.1

 

SUBSIDIARIES OF NABRIVA THERAPEUTICS plc

 

Nabriva Therapeutics GmbH

 

Austria

 

 

 

Nabriva Therapeutics Ireland Designated Activity Company

 

Ireland

 

 

 

Nabriva Therapeutics One Designated Activity Company (In Voluntary Liquidation)

 

Ireland

 

 

 

Nabriva Therapeutics US, Inc.

 

United States

 


Nabriva Therapeutics plc Reports